Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nOPV1 Safety and Immunogenicity in Bangladeshi Children, Infants, and Neonates
NCT05644184Phase 2Completed
- Sponsor
- PATH
- Start
- Mar 2023
- Primary completion
- Sep 2026
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Novel oral polio vaccine type 1 in poliomyelitis, sponsored by PATH. Started Mar 2023; status: completed.
02
Drugs
Novel oral polio vaccine type 1
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT05644184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05644184.